Cigna is building on client demand ... announced on Thursday that it had inked a deal with Danish drugmaker Novo Nordisk, which manufactures the GLP-1 Wegovy, to give Wegovy preferred placement ...

Cigna (NYSE:CI) on Friday announced plans to launch a new specialized GLP-1 pharmacy called ENGUIDE from next month, as the obesity drug class popularized by Novo Nordisk (NVO) and Eli Lilly (NYSE ...

Cigna’s Evernorth has reached new deals with manufacturers Eli Lilly and Novo Nordisk to cap patients ... costs at $200 per month and reduces GLP-1 prices for their plan sponsor.

Only half of health insurer Cigna's clients currently cover the popular GLP-1 weight loss ... drug makers Ely Lilly and Novo Nordisk which it said will bring prices down for employers and their ...

Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...

Cigna's Evernorth is rolling out a new pharmacy benefit management program that caps members' monthly cost for key GLP-1 drugs. Evernorth said in an announcement that through its Express Scripts ...

Cigna (CI) CEO David Cordani is not convinced ... discussing a number of issues, including GLP-1 benefits and coverage. "About 50% of large employers have chosen to cover it for weight management.

He spoke at the Economic Club of D.C. Wednesday, discussing a number of issues, including GLP-1 benefits and coverage. Cigna CEO David ... Zepbound and Novo Nordisk's (NVO) Wegovy.